World Alzheimer's Day

Rate of Alzheimer’s Cases in the U.S. Has Doubled Since 2000

The rate of people dying of Alzheimer’s disease in the United States has doubled since the year 2000, according to the Alzheimer’s Association's latest report. Where an average of 17.6 people per 100,000 died from the form of dementia at the turn of the millennium, the figure had climbed to 34 per 100,000 people as of 2023.

This is likely the result of an aging population, since age is the predominant risk factor for Alzheimer’s dementia. However, it could also reflect a rise in the number of formal diagnoses of the disease or even in the number of physicians who are reporting Alzheimer’s as a cause of death.

The number of deaths from dementia spiked in 2020 in the U.S., with one in every 10 death certificates that year listing Covid-19 as the primary cause of death also listing Alzheimer’s disease or another dementia as a multiple cause of death. Among people aged 85 or older who died of Covid-19 in 2020 or 2021, Alzheimer’s disease or another dementia was listed as a multiple cause of death on almost a quarter of death certificates. According to the Alzheimer’s Association, this is largely due to the fact that nursing homes and long-term care facilities were the site of major outbreaks in the early stages of the pandemic, with residents with Alzheimer’s particularly vulnerable.

Dementia is often underdiagnosed, with some studies indicating that such underdiagnosis is higher in Black and Hispanic older adults. This can lead to harms such as delayed access to treatment and supportive services as well as less time for care planning. Early symptoms of Alzheimer’s disease include difficulty remembering recent conversations, names or events, apathy and depression.

Description

This chart shows the number of deaths from Alzheimer's disease per 100,000 people in the United States between 2000 and 2023.

Download Chart
Death rate due to Alzheimer's Disease in the U.S. 2000-2022
Knowledge of Alzheimer's disease and related conditions among U.S. adults 2024
Alzheimer’s disease therapies in phase III development 2025, by type
Share of people worried about developing Alzheimer's disease in the U.S. 2024
Perceived importance of early Alzheimer's disease diagnosis among U.S. adults 2024
Stage at which U.S. adults would want to know if they have Alzheimer’s disease 2024

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!

Do you still have questions?

Feel free to contact us anytime using our contact form or visit our FAQ page.

Statista Content & Design

Need infographics, animated videos, presentations, data research or social media charts?

More Information